A recent study has demonstrated that the malaria drug chloroquine normalizes the abnormal blood vessels in tumors, which can aid in blocking cancer cell dissemination and metastasis.
Para-aortic radiation with 36 Gy linked to increased diabetes mellitus risk
The leukemia drug dasatinib shows promise as a treatment for skin, breast, and several other cancers, according to new research.
Researchers believe that a staple of Earth science research can be used in biomedical settings to predict the course of disease.
A biomarker strongly linked to basal-like breast cancer has been identified.
Although mutations in a gene dubbed the "guardian of the genome" are recognized as being associated with more aggressive cancers, evidence suggests that the deleterious health effects of the mutated gene may in large part be due to other genetic abnormalities.
WHO recommendation came a day after similar calls for e-cigarette regulation by American Heart Association.
A triple therapy for glioblastoma, consisting of two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report.
Healthy men participating in the Prostate Cancer Prevention Trial who actively participate in all trial steps are most likely to undergo a biopsy at the end of the trial, according to recent research.
A drug originally used to treat ovarian cancer has shown promising results in patients with advanced peritoneal cancers during a phase I clinical trial.
Adoptive T-cell therapy, a type of immunotherapy, appears to recognize unique cancer mutations that stimulate immune responses.
A new lung screening service for persons at high risk for lung cancer with incorporates a same-day visit by a nurse practitioner after the patient undergoes low-dose CT to discuss test results and recommendations.
Although nurses are familiar with palliative care guidelines related to cancer anorexia-cachexia syndrome, a needs-assessment survey revealed they are less familiar with novel therapeutic interventions in development.
Burnout was reduced and secondary trauma improved by a 6-week initiative to prevent compassion fatigue.
Pre- and postimplementation surveys are effective tools to confirm staff understanding of and adherence to a new neurologic assessment process for patients receiving high-dose cytarabine.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|